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Abstract
Purpose: To evaluate changes in cup/disc (C/D) diameter ratios and parapapillary atrophy in patients with non-arteritic
anterior ischemic optic neuropathy (NA-AION), using morphometric methods.
Methods: The clinical non-interventional study included 157 patients with unilateral or bilateral NA-AION. Optic disc
photographs taken from both eyes at the end of follow-up were morphometrically examined.
Results: Follow-up was 86.3670.3 months. Horizontal and vertical disc diameters (P=0.30;P=0.61, respectively), horizontal
and vertical C/D ratios (P=0.47;P=0.19,resp.), and size of alpha zone and beta zone of parapapillary atrophy
(P=0.27;P=0.32,resp.) did not differ significantly between affected eyes and contralateral normal eyes in patients with
unilateral NA-AION. Similarly, horizontal and vertical disc diameters, horizontal and vertical C/D ratios, and size of alpha zone
and beta zone did not vary significantly (all P.0.05) between the unaffected eyes of patients with unilateral NA-AION and the
eyes of patients with bilateral NA-AION. Optic disc diameters, C/D ratios, size of alpha zone or beta zone of parapapillary
atrophy were not significantly associated with final visual outcomein the eyes affected with NA-AION (all P.0.20) norwith the
difference in final visual acuity between affected eyes and unaffected eyes in patients with unilateral NA-AION (all P.0.25).
Conclusions: NA-AION did not affect C/D ratios nor alpha zone and beta zone of parapapillary atrophy. Optic disc size was
not related to the final visual acuity outcome in NA-AION.
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Introduction
Non-arteritic anterior ischemic optic neuropathy (NA-AION) is
an acute ischemic disorder of the optic nerve head [1], occurring
with an incidence rate of about 2 to 10 per 100,000 subjects [2–5].
Although the association of NA-AION with absent or a small cup/
disc ratio (C/D) has been reported by several studies since 1974
[6–20], little information on the following aspects about NA-
AION has been gathered so far:
1. Whether within the groups of patients with NA-AION, eyes
with the smaller optic disc have a higher risk to become
affected?
2. Whether there are differences between affected eyes and
unaffected eyes of the same individuals in the size of alpha zone
and beta zone of parapapillary atrophy at the end of the follow-
up [21,22], in addition to the question whether affected eyes
and unaffected eyes of the same individuals differ in size and
shape of the neuroretinal rim at the end of the follow-up
3. Whether final visual outcome in the affected NA-AION eyes is
associated with the optic disc diameter, cup/disc diameter (C/
D) ratio, or size of alpha zone or beta zone of parapapillary
atrophy.
The objective of the present study was, therefore, to investigate
the above aspects of NA-AION eyes by measuring the optic nerve
head by a morphometric method in a larger number of patients
with: (i) unilateral NA-AION and (ii) bilateral NA-AION, several
months after the acute onset of the disorder, when the optic disc
edema had resolved.
Methods
Ethics Statement
The Institutional Review Board of the College of Medicine,
University of Iowa, approved the study protocol, and all patients
agreed upon inclusion into this observational study. At the time
when the study was designed, a written consent of patients
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follow-up was not necessary. A written consent was required for
any invasive procedure none of which was performed in the
present observational study.
The prospective clinical non-observational study included a
cohort of patients with NA-AION, who were prospectively
examined and diagnosed by the same clinician (SSH) in the
Ocular Vascular Clinic at the University of Iowa Hospitals and
Clinics, as a part of a National Institute of Health funded (RO1)
prospective study. The study population was divided into a
subgroup of patients with unilateral NA-AION and a second
subgroup of patients with bilateral NA-AION. In patients with
bilateral NA-AION, the optic neuropathy involved one eye before
the second eye. The patients with bilateral NA-AION entered the
study when the second eyes were acutely affected. The ratio
between the unilateral and bilateral NA-AION in this study does
not reflect the actual prevalence seen [1].
Criteria required for diagnosis of NA-AION and inclusion
in this study. These included:
(1) A history of sudden visual loss, usually discovered in the
morning; and this was not due to any ocular, systemic or
neurological diseases.
(2) Optic disc edema at onset must have been documented in the
Ocular Vascular Clinic or by another ophthalmologist.
(3) Spontaneous resolution of optic disc edema was observed.
(4) The eye had optic disc-related visual field defects.
(5) . Satisfactory stereoscopic photographs of both optic discs had
to be available at baseline and the end of follow-up.
Exclusion criteria. All patients with any ocular, systemic or
neurological diseases, that might influence or explain the patient’s
visual loss, were excluded. NA-AION patients with only
background diabetic retinopathy were included, but those who
had active neovascularization, vitreous hemorrhages, traction
detachment or other complications influencing the visual acuity or
fields were excluded. Patients who had a diagnosis of glaucoma
were excluded.
At the first visit to our clinic, a detailed ophthalmic and medical
history was obtained from all these patients (by SSH). A complete
ophthalmic evaluation was performed at that time (by SSH) for
each patient; this included Snellen visual acuity, visual fields
plotted with a Goldmann perimeter, relative afferent pupillary
defect, intraocular pressure measurement, slit lamp examination of
the anterior segment, direct and indirect ophthalmoscopy,
stereoscopic color fundus photography, and in acute cases
stereoscopic fundus fluorescein angiography. Stereoscopic color
fundus photographs of both eyes were taken at the initial visit and
later on. At the same time, a detailed systemic evaluation was
performed by a cardiologist, internist or the patient’s local
physician. If giant cell arteritis was suspected, a temporal artery
biopsy was performed. The erythrocyte sedimentation rate and the
serum concentration of the C-reactive protein were within the age-
related limits for all patients included into the study. None of the
patients included into the study complained about symptoms
typical for giant cell arteritis, jaw claudication, anorexia and
unintended weight loss in the months preceding the onset of the
acute vision loss, nor had positive temporal artery biopsy for giant
cell arteritis. If indicated, patients had carotid duplex scans,
carotid angiograms and/or echocardiography. The study design
has been described in detail previously [17,23].
The optic disc photographs of both eyes of the patients in this
study were digitized and we assessed and measured the horizontal
and vertical optic cup and optic disc diameters and the presence
and maximal width of alpha zone and beta zone of parapapillary
atrophy. The optic disc was defined as all area within the
peripapillary scleral [21,22]. The optic cup was defined on the
basis of contour and not of color. Parapapillary atrophy was
differentiated into alpha zone and beta zone. Alpha zone was
defined as peripheral zone with irregular hyperpigmentation and
hypopigmentation, and beta zone was characterized by visible
large choroidal vessels and visible sclera [21,22]. If beta zone was
present, it was adjacent to the peripapillary scleral ring and
interposed between this ring and alpha zone. All optic disc
structures were measured in relative size units as given by the
planimetric computerized measurement program. Masking of the
examiners was not possible since the diagnosis could be detected
on the appearance (i.e. of the optic disc), which was to be
measured. The optic disc images taken in eyes with unilateral NA-
AION as well as in the fellow normal eyes were examined at the
end of the follow-up period. This was because at the end of the
follow-up, the optic disc edema had completely resolved, so that
the border of the optic disc (i.e. the inner margin of the
peripapillary scleral ring) and the border between the optic cup
and neuroretinal rim could be clearly visualized. In a similar
manner in patients with bilateral NA-AION, stereoscopic photo-
graphs of both optic discs taken at the end of follow-up were
morphometrically examined.
The statistical analysis was performed using a commercially
available statistical software package (SPSS for Windows, version
19.0, SPSS, Chicago, IL). The data were presented as mean 6
standard deviation (SD). Only measurements of optic nerve head
images obtained at the end of the follow-up were used for the
statistical analysis. For comparison between the affected eyes and
the contralateral unaffected eyes in the patients with unilateral
NA-AION, the non-parametric Wilcoxon test for paired samples
was applied. For the comparison of optic disc measurements
between patients with unilateral NA-AION and patients with
bilateral NA-AION, the non-parametric Mann-Whitney test for
un-paired samples was taken. All P-values were 2-sided and were
considered statistically significant when the values were less than
0.05.
Results
The study comprised 157 patients (38.9% women) with a mean
age of 58.5612.1 years (median: 59.8 years). The mean follow-up
was 86.3670.3 months (median: 74.1 months). Of the 157 patients
included in this study, 70 (32 in the right eye and 38 in the left) had
unilateral NA-AION, and 87 bilateral. These two groups did not
vary significantly in age (P=0.38) nor in gender (P=0.26).
Optic Disc Diameters
In patients with unilateral NA-AION (n=70), comparing the
affected eyes with the unaffected contralateral eyes revealed that
the horizontal disc diameter (P=0.30) and the vertical disc
diameter (P=0.61) did not differ significantly (Table 1). Compar-
ing the optic disc diameters of the unaffected eyes of the patients
with unilateral NA-AION (n=70) with the optic disc diameters of
the patients with bilateral NA-AION (n=87) showed that the
horizontal optic disc diameter did not vary between the unaffected
eyes in the unilateral NA-AION group versus both eyes in the
bilateral NA-AION group (unaffected eyes versus for right eyes of
bilaterally affected patients: P=0.06; and versus left eyes of
bilaterally affected patients: P=0.11). In a similar manner, the
vertical optic disc diameter did not vary between the unaffected
eyes in the unilateral NA-AION group versus both eyes in the
bilateral NA-AION group (unaffected eyes versus right eyes of
Optic Disc Morphology in NA-AION
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bilaterally affected patients: P=0.26) (Table 1).
Cup/Disc Diameter Ratios
In patients with unilateral NA-AION (n=70), a comparison of
the affected eyes with the unaffected contralateral eyes revealed
that the horizontal C/D ratio (P=0.47) and the vertical C/D ratio
(P=0.19) did not differ significantly between both eyes (Table 1).
Comparing the C/D ratios of the unaffected eyes of the patients
with unilateral NA-AION (n=70) with the C/D ratios of the
patients with bilateral NA-AION (n=87) showed that the
horizontal C/D ratio did not differ between the unaffected eyes
in the unilateral NA-AION group versus either eye in the bilateral
NA-AION group (unaffected eyes versus right eyes of bilaterally
affected patients: P=0.07; and versus left eyes of bilaterally
affected patients: P=0.33). In a similar manner, the vertical C/D
ratio did not vary between the unaffected eyes in the unilateral
NA-AION group versus either eye in the bilateral NA-AION
group (unaffected eyes versus right eye of bilaterally affected
patients: P=0.06; and versus left eyes of bilaterally affected
patients: P=0.22) (Table 1). The C/D ratios and the disc size did
not differ between the affected eyes and the unaffected eyes of
patients with unilateral NA-AION; similarly, the size and shape of
the neuroretinal rim and optic cup did not differ between the two
eyes.
Parapapillary atrophy
In patients with unilateral NA-AION, comparison of the
affected eyes with the unaffected contralateral eyes revealed that
the greatest diameter of alpha zone (0.6160.44 units versus
0.7560.38 units; P=0.27) and beta zone (0.2360.49 units versus
0.1960.51 units; P=0.32) did not differ significantly between the
two eyes. Comparing the greatest diameters of alpha zone and
beta zone of the unaffected eyes of the patients with unilateral NA-
AION with the greatest diameters of alpha zone and beta zone of
the patients with bilateral NA-AION showed that the greatest
diameters of alpha zone did not vary between the unaffected eyes
in the unilateral NA-AION group versus either eye in the bilateral
NA-AION group (P=0.20 and P=0.66, respectively). Likewise,
the greatest diameter of beta zone did not vary between the
unaffected eyes in the unilateral NA-AION group versus either eye
in the bilateral NA-AION group (P=0.30 and P=0.45, respec-
tively).
Final Visual Acuity
Final visual acuity in the affected right eyes was worse than 20/
200 in 11.7% of the patients, and worse than 20/40 in 35.1% of
the patients. Final visual acuity in the affected left eyes was worse
than 20/200 in 10.5% of the patients, and worse than 20/40 in
35.5% of the patients. In patients with unilateral NA-AION, final
visual acuity (logMAR) of the affected eye was not significantly
associated with the horizontal or the vertical optic disc diameter,
the horizontal or vertical C/D ratio, and nor the greatest diameter
of alpha zone and beta zone of parapapillary atrophy in the eyes
affected with NA-AION (P=0.54, P=0.65, P=0.76, P=0.71,
P=0.75, and P=0.21, respectively) nor with the corresponding
parameters of the unaffected eyes (P=0.70, P=0.80, P=0.23,
P=0.11, P=0.18, and P=0.35, respectively).
Assuming that visual acuity did not differ significantly between
both eyes of the same individual before the onset of NA-AION, we
calculated the loss in visual acuity as the difference in visual acuity
between the unaffected eye and the affected eye for the patients
with unilateral NA-AION. It revealed that visual acuity loss was
not significantly associated with the horizontal or the vertical optic
disc diameter, the horizontal or vertical C/D ratio, the greatest
diameter of alpha zone and beta zone of parapapillary atrophy in
the eyes affected with NA-AION (P=0.75, P=0.73, P=0.49,
P=0.98, P=0.82, and P=0.26, respectively) nor with the
corresponding parameters of the contralateral eyes unaffected by
NA-AION (P=0.30, P=0.33, P=0.95, P=0.68, P=0.93, and
P=0.24, respectively).
Discussion
Our study was performed with the objective of addressing
questions in NA-AION on which there is so far little information.
Following are the questions and the answers provided by our study
results.
Within the groups of patients with NA-AION, do eyes
with the smaller optic disc have a higher risk of being
affected?
NA-AION did occur preferentially in eyes with small optic
nerve heads; but there was no statistically significant difference in
optic disc size in the two eyes of patients with unilateral NA-
AION, nor between patients with unilateral NA-AION and
bilateral NA-AION. Saito and colleagues also found no significant
difference in disc area between NA-AION affected eyes and the
unaffected fellow eyes [20].
Table 1. Measurements (Mean 6 Standard Deviation) of Optic Disc Parameters in Patients with unilateral or bilateral non-arteritic
anterior ischemic optic neuropathy (NA-AION).
Unilateral NA-AION Bilateral NA-AION
Affected Eye Unaffected Eye P-Val. Right Eyes Left Eyes
Optic Disc Diameter
Horizontal 4.5460.49 4.6160.48 0.30 4.4960.44 (P*=0.11) 4.6660.53 (P*=0.06)
Vertical 4.7160.57 4.8460.52 0.61 4.7460.63 (P*=0.26) 4.8160.54 (P*=0.43)
Cup/Disc Diameter Ratio
Horizontal 0.1960.14 0.2060.11 0.47 0.1860.12 (P*=0.33) 0.2260.15 (P*=0.07)
Vertical 0.2160.15 0.2060.12 0.19 0.1860.12 (P*=0.22) 0.2460.16 (P*=0.06)
P-Val.: Statistical significance of the difference between the affected eyes and the unaffected eyes of patients with unilateral NA-AION.
P*: Statistical significance of the difference between the eyes of patients of bilateral NA-AION and the unaffected eyes of patient with unilateral NA-AION.
doi:10.1371/journal.pone.0037499.t001
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unaffected eyes of the same individuals in the size of
alpha zone and beta zone of parapapillary atrophy at the
end of the follow-up?
The alpha zone and beta zone of parapapillary atrophy did not
differ between the eyes affected by NA-AION and the contralat-
eral eyes, or between the unaffected eyes of the patients with
unilateral NA-AION and the affected eyes of the patients with
bilateral NA-AION. This supports a previous smaller study [13]. It
shows a difference between eyes with glaucomatous optic
neuropathy and NA-AION with optic nerve damage: while in
glaucoma, parapapillary atrophy enlarges and shows a spatial
relationship with the loss of neuroretinal rim inside of the optic
disc and with the longest distance to the central retinal vessel trunk
[24], parapapillary atrophy in NA-AION does not change
markedly. This gives another criterion to differentiate between
glaucoma and NA-AION. Interestingly, arteritic AION, like NA-
AION, is also not associated with an enlargement of parapapillary
atrophy, so that the loss of rim and deepening of the optic cup are
the main morphological differences between the two types of
AION [25]. This reflects differences in the pathogeneses of
ischemic optic neuropathies (acute ischemic disorders) and
glaucomatous optic neuropathies (chronic ischemic disorders)
[26–29].
In unilateral NA-AION, is there a difference in size and
shape of the neuroretinal rim at the end of the follow-
up?
Our study showed no difference in optic disc cup and C/D
diameter between the affected eyes and their contralateral
unaffected eyes. This confirms previous investigations [6–20]. It
corresponds with the finding that the C/D ratios, as surrogates of
the optic disc size [30], were markedly lower in our study
population (mean horizontal C/D ratios: 0.2060.13; mean
vertical C/D ratio: 0.2060.14) than in the normal eyes of the
Rotterdam Study (mean horizontal C/D ratio: 0.4060.14; vertical
C/D ratio: 0.4960.14) [31]. It agrees with the already reported
association between of NA-AION and absent or small optic disc
cup [6–20]. The results in particular confirm a previous
investigation by Danesh-Meyer and colleagues [15], who applied
confocal laser scanning laser tomography to quantify the
morphological appearance of the optic nerve morphology in 23
patients after NA-AION. Images were taken of both affected and
unaffected eyes, with the latter serving as controls. Danesh-Meyer
and coworkers found that the rim area was 6% smaller (P=0.13)
in the affected eyes than in the fellow eyes, and the authors
concluded that the optic cup after an event of NA-AION did not
enlarge.
Since the C/D ratio did not differ between the affected eyes and
the contralateral unaffected eyes at the end of follow-up in our
study, it suggests that size and shape of the neuroretinal rim did
not change due to NA-AION. This is in contrast to the loss of
neuroretinal rim and widening and deepening of the optic cup
observed in eyes after arteritic anterior ischemic optic neuropathy
[25,32–35], and in eyes with any type of glaucoma. It is not clear
why the ischemic event in the vast majority of NA-AION eyes is
not associated with a loss in neuroretinal rim, although optic nerve
fibers are lost, as in glaucoma and as in arteritic anterior ischemic
optic neuropathy. The finding puts NA-AION into the same
group of non-glaucomatous optic neuropathies such optic nerve
damage due to optic nerve compression or transection, or central
retinal artery occlusion, in which the size and shape of the
neuroretinal and optic cup do not markedly change in spite of
extensive loss of nerve fibers [36]. It is possible that in these eyes
there is associated secondary gliosis which replaces the optic nerve
fiber loss.
Is the final visual acuity outcome in the affected NA-AION
eyes associated with the optic disc diameters, C/D ratios,
or size of alpha or beta zone of parapapillary atrophy?
The study showed that not to be the case.
Our study agrees with previous investigations applying optical
coherence tomography as technique to examine the optic nerve
head. In a study by Suh and colleagues, the ratio of neuroretinal
rim to retinal nerve fiber layer thickness showed significant
differences between eyes with NA-AION and eyes with open-angle
glaucoma suggesting that the neuroretinal rim was mostly
preserved in the eyes with NA-AION [37]. Correspondingly, our
study showed that the cup/disc ratio (and thus indirectly the
neuroretinal rim) did not differ markedly between the eyes affected
by NA-AION and the contralateral unaffected eyes. In a similar
manner in a study by Chan and coworkers, patients with NA-
AION had smaller optic cups and cup/disc area ratios in both eyes
compared with controls [19]. In an investigation by Contreras and
coworkers, patients with NA-AION also had lower cup/disc ratios
than a normal population [38]. Interestingly, Contreras and
colleagues did not find a significant difference in optic disc size
between patients with NAION and the control subjects.
Potential limitations of our study
Some may consider that our study has the following limitations.
Following are our responses to that.
First, the magnification of the optic nerve head images by the
optic media and the fundus camera was not corrected. Since,
however, parameters such as the horizontal and vertical C/D
ratios do not depend on the magnification of the optic disc
photograph and since most of the findings reported in our study
were based on an inter-eye comparison in individuals, the missing
correction of the optic disc structure measurements should not
have appreciably influenced the results and conclusions of the
study.
Second, modern imaging techniques such as confocal laser
scanning tomography of the optic nerve head or optical coherence
tomography were not available when the patients were primarily
examined in our study. These techniques can measure the three-
dimensional topography of the optic nerve head and may thus
have an advantage over the two-dimensional assessment of optic
disc photographs. However, a study by Danesh-Meyer e al. [15],
using the modern techniques, proved what our study showed.
Third, the optic nerve head measurements were taken on
photographs performed after the development of NA-AION and
resolution of optic disc edema. Therefore, we had to use the fellow
normal eye as surrogate for the pre-NA-AION state of the optic
disc in the involved eye. It would evidently have been better if
photographs had been available from before the development of
NA-AION but that is obviously not possible, since the patients
come for consultation only when they lose vision, so this goal was
not achievable. The post hoc analysis of photographs after
resolution of the optic disc swelling at the end of the follow-up
may therefore, have been an acceptable compromise.
Fourth, it would have been interesting not only to compare the
C/D ratios as surrogate for the disc size, but additionally to
compare the disc diameters between the participants of our study
and the participants of population-based studies, such as the
Rotterdam Study [31]. This comparison was, however, not
possible since the correction of the magnification of fundus
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a bias.
Fifth, some may consider that the follow-up of the patients may
not have been long enough. A previous study of 380 consecutive
eyes with NA-AION showed, however, that optic disc edema
usually resolved spontaneously in about 8 weeks [39], and after
that the optic disc remained stable. A follow-up of 2 months as
used in our study as inclusion criterion therefore appeared to have
been adequate to provide valid information.
Sixth, the follow-up may not have been sufficient to obtain
reliable information about the final visual acuity. A previous study
[23] on the natural history of visual outcome in 386 eyes with NA-
AION showed that 6 months after onset of NA-AION, there was
no change in visual acuity and visual fields. That was also shown
by the Ischemic Optic Neuropathy Decompression Trial Research
Group [40]. In view of that, NA-AION patients with a minimum
follow-up of 6 months for visual acuity may therefore have
provided all the information required in the present study. In this
study the mean follow-up was 86.3670.3 months (median: 74.1
months) and the patients within the two subgroups were followed
for longer than 6 months.
Seventh, the study design would have improved by including a
normal control group. The data of the study groups of our
investigation were, however, compared with the normative data of
the population-based Rotterdam Study so that the data of a
normal control group were indirectly included into the present
study.
Eight, the unaffected eyes of the patients with unilateral NA-
AION as compared to normal eyes of normal subjects have an
increased risk to get affected by NA-AION sometime later on than
the end of follow-up in this study [1]. The unaffected eyes of the
patients with unilateral NA-AION as compared to normal eyes of
normal subjects have no cup or only a small cup [6–20].
Therefore, using parameters of the unaffected eyes of the patients
with unilateral NA-AION as a control was logical for the involved
eyes. That helped, to explore the optic disc morphology after NA-
AION.
Ninth, when we calculated the NA-AION induced loss in visual
acuity as the difference in visual acuity between the unaffected eye
and the affected eye, we assumed that the visual acuity did not
differ significantly between both eyes of the same individual before
the onset of NA-AION, i.e. it was normal in both eyes unless
patient had noted any difference, and that disqualified the patient
for this study.
Conclusion
NA-AION did not affect C/D ratios, so that the size and shape
of the neuroretinal rim and optic cup in this study were not
changed by NA-AION. The unchanged size and shape of the
neuroretinal rim differentiated NA-AION from arteritic AION
and glaucomatous optic neuropathy. Neither alpha zone nor beta
zone of parapapillary atrophy was affected by NA-AION, giving
another differential criterion between NA-AION and glaucoma.
Within the groups of patients with NA-AION, disc size was not
related with the occurrence of NA-AION or final visual outcome.
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